Priogen is an innovative diagnostic company specializing in protein amplification assays for detecting prion diseases in wildlife, livestock, and humans. We provide novel diagnostic solutions that can prevent prion disease spread and stabilize multiple economic sectors. 

Priogen's entry into the protein-diagnostic market strategically focuses on Chronic Wasting Disease (CWD), a disease of cervids (deer, elk, moose, caribou) spreading across North America, Scandinavia, and Korea. In the United States alone, CWD is an economic threat of over $200 billion. The disease continues to spread and concerns of infectious CWD prions causing disease in humans and livestock are increasing. For these reasons, Priogen is stepping forward to help fight the spread of CWD.  

Our mission is to provide accessible technologies and services that revolutionize the prion diagnostic industry


In 2021 Priogen’s founding team was the first to successfully test for CWD in a field setting using our MN-QuIC™ technology, with results in less than 24 hours. We have since produced a strong, portfolio of proprietary diagnostic solutions for identifying prions in biological and environmental samples. Priogen’s scientists have designed nanotechnology-based diagnostic platforms that are portable and provide same-day results for CWD. These technologies have capabilities for human and animal prion and protein-misfolding diseases.